James Christopher Barry - 25 Jun 2021 Form 4 Insider Report for NUVASIVE INC

Role: Chief Executive Officer, Director
Signature: /s/ Nathaniel B. Sisitsky, Attorney-in-fact for James Christopher Barry
Issuer symbol: N/A
Transactions as of: 25 Jun 2021
Net transactions value: -$350,000
Form type: 4
Filing time: 29 Jun 2021, 17:45:33 UTC
Previous filing: 23 Jun 2021
Next filing: 03 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUVA	Common Stock	Sale	$350,000	-5,000	-33%	$70.00	9,926	25 Jun 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
F2	Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.